Bridge Biotherapeutics (XKRX:288330) FCF Yield % : -54.44 (As of Jun. 03, 2024)

Bridge Biotherapeutics FCF Yield % Chart

Bridge Biotherapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-21.00	-31.04	-34.49	-37.26	-23.49

Competitive Comparison of Bridge Biotherapeutics's FCF Yield %

For the Biotechnology subindustry, Bridge Biotherapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bridge Biotherapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bridge Biotherapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Bridge Biotherapeutics's FCF Yield % falls into.

Bridge Biotherapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Bridge Biotherapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

Bridge Biotherapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bridge Biotherapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Bridge Biotherapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Bridge Biotherapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bridge Biotherapeutics (XKRX:288330) Business Description